Immunomedics (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Immunomedics" in English language version.

refsWebsite

Global rank English rank

4,625^th place

2,767^th place

1businesswire.com

615^th place

407^th place

low place

6,978^th place

572^nd place

436^th place

1fiercepharma.com

low place

8,921^st place

447^th place

338^th place

2^nd place

2^nd place

4^th place

4^th place

1semanticscholar.org

11^th place

8^th place

businesswire.com

"Gilead Sciences Completes Acquisition of Immunomedics, Inc" (Press release). Business Wire. October 23, 2020.

doi.org

Chen, X; Chang, C-H; Stein, R; Goldenberg, D M (October 24, 2011). "The humanized anti-HLA-DR moAb, IMMU-114, depletes APCs and reduces alloreactive T cells: implications for preventing GVHD". Nature. 47 (7): 967–980. doi:10.1038/bmt.2011.203. PMID 22020022. S2CID 8988947.

fda.gov

"FDA Approves New Therapy for Triple Negative Breast Cancer That Has Spread, Not Responded to Other Treatments" (Press release). Food and Drug Administration. April 22, 2020.

fiercepharma.com

"Gilead Sciences will lay off 114 staffers based out of former Immunomedics headquarters". 8 March 2022.

nih.gov

pubmed.ncbi.nlm.nih.gov

Chen, X; Chang, C-H; Stein, R; Goldenberg, D M (October 24, 2011). "The humanized anti-HLA-DR moAb, IMMU-114, depletes APCs and reduces alloreactive T cells: implications for preventing GVHD". Nature. 47 (7): 967–980. doi:10.1038/bmt.2011.203. PMID 22020022. S2CID 8988947.

sec.gov

"Immunomedics Form 8-K". U.S. Securities and Exchange Commission. February 22, 2019.

semanticscholar.org

api.semanticscholar.org

Chen, X; Chang, C-H; Stein, R; Goldenberg, D M (October 24, 2011). "The humanized anti-HLA-DR moAb, IMMU-114, depletes APCs and reduces alloreactive T cells: implications for preventing GVHD". Nature. 47 (7): 967–980. doi:10.1038/bmt.2011.203. PMID 22020022. S2CID 8988947.

thestreet.com

Feuerstein, Adam (January 25, 2017). "Immunomedics Sale Hinges on Proxy Battle Over Fate of Controversial Founder". TheStreet.com.
LEE, ARMIE MARGARET (May 5, 2017). "Immunomedics, Seattle Genetics Scrap License Deal". TheStreet.com.

xconomy.com

Vinluan, Frank (February 28, 2019). "Immunomedics CEO Michael Pehl Resigns". Xconomy.